Richards Timothy T. 4

What Happened Timothy T. Richards, a director of ClearPoint Neuro, acquired 442 shares on April 1, 2026 as an award/other acquisition (transaction code A). The shares were issued at $9.10 each for a total value of $4,022 and were granted as payment of director fees rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-04-01, 442 shares at $9.10 per share (total $4,022).
• Transaction type: A = Award/other acquisition (shares issued as compensation).
• Source/footnote: Shares issued under the Sixth Amended and Restated 2013 Incentive Compensation Plan in payment of fees under the Non-Employee Director Compensation Plan; issued at the issuer’s closing price on March 31, 2026.
• Shares owned after transaction: Not disclosed in this filing.
• Timeliness: Form 4 filed April 2, 2026 for a 2026-04-01 transaction (appears timely; Form 4s are generally due within two business days).

Context This was an equity compensation award for director fees, not an open-market purchase or sale. Such awards are routine corporate compensation and do not necessarily indicate the director’s personal trading intent.